VKH
APDNW

Virtu KCG Holdings’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Virtu KCG Holdings’s Portfolio APDNW Stock Details APDNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,174
Closed -$6K – 3761
2017
Q1 		$6K Sell
15,174
-16,044
-51% -$7.29K ﹤0.01% 3040
2016
Q4 		$16K Buy
+31,218
New +$24.8K ﹤0.01% 3259

Other funds holding APDNW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu KCG Holdings's APDNW Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q2 2017, closing a stake of 15,174 shares — an estimated $6K sold.

Virtu KCG Holdings first reported a position in APDNW in Q4 2016 and held it in 2 quarters. The position peaked at $16K in Q4 2016. 6 funds tracked by Wall St. Rank hold APDNW as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Applied DNA Sciences Inc Warrant position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 15,174 Applied DNA Sciences Inc Warrant shares in Q2 2017, an estimated $6K.
  • Virtu KCG Holdings first reported a position in Applied DNA Sciences Inc Warrant in Q4 2016 and held it in 2 quarters.
  • Virtu KCG Holdings's Applied DNA Sciences Inc Warrant position peaked at $16K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.